IBA signs contract with Yale New Haven Health and Hartford HealthCare to Install Proteus ONE Proton Therapy Solution


May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the Connecticut Proton Therapy Center, a collaboration between Yale New Haven Health, Hartford HealthCare and Proton International, for the installation of a Proteus ONE compact proton therapy system. The contract includes a multi-year operation and maintenance agreement, and it is expected that the center will start treating patients in the spring of 2026. The first downpayment has been received.

The Connecticut Proton Therapy Center will be the first of its kind in the state, and located in Wallingford, Connecticut. Proton therapy treatments will be provided by physicians affiliated with the Yale School of Medicine, the Yale New Haven Smilow Cancer Hospital, and Yale Cancer Center, which is a National Cancer Institute-designated (NCI) Comprehensive Cancer Center, and the Harford HealthCare Cancer Institute.

IBA’s Proteus ONE, as the only user-centric compact Imaged Guided Intensity Modulated Proton Therapy solution, includes an isocentric Cone Beam Computed Tomography (CBCT) system and an open gantry enabling high-quality treatments with optimized patient throughput and excellent user and patient experience.

The typical end-user price for a Proteus ONE system with a multi-year maintenance contract ranges between 40-50 million US dollars.

Olivier Legrain, Chief Executive Officer of IBA, commented: We are very proud to have signed this contract, which, once installed, will provide patients in Connecticut with access to cutting-edge proton therapy technology. We look forward to working with Yale New Haven Health and Hartford HealthCare Corporation as they seek to deliver world-class cancer care to patients.”    

Peter Glazer, MD, PhD, chief of Radiation Oncology, Yale New Haven Hospital and chair, Therapeutic Radiology, Yale School of Medicine added: “We are pleased to have secured IBA as the technology leader to move forward with our proton therapy initiative, completing our panel of comprehensive cancer care. Our oncology experts are excited to provide this life changing treatment to our patients.”

Andrew Salner, M.D., Director of the Hartford HealthCare Cancer Institute, stated: “We are proud to be part of the first proton therapy project in the State of Connecticut and look forward to seeing the benefit to our community. Working with IBA will enable us to offer patients with the latest and most advanced proton therapy technology.”

Chris Chandler, Chief Executive Officer of Proton International LLV., said: “We are honored to assist the Connecticut Proton Therapy Center for the design and development of the facility which will be the first proton cancer treatment center in the State of Connecticut. At the moment patients have to travel out of state, the nearest locations being in New York City and Boston, to receive this advanced option for cancer treatment.”

For more information: www.iba-worldwide.com


Leave a Reply

Your email address will not be published. Required fields are marked *